From the National Institutes of Health.
Raub
W
W
D001171:Arthritis, Juvenile / Q000276:immunology*; D001249:Asthma / Q000188:drug therapy; D015704:CD4 Antigens / Q000494:pharmacology*; D002478:Cells, Cultured; D005098:Exotoxins / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects*; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000922:Immunotoxins / Q000494:pharmacology*; D016859:Lipoxygenase Inhibitors; D009316:National Institutes of Health (U.S.); D011994:Recombinant Proteins / Q000494:pharmacology*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D013601:T-Lymphocytes / Q000166:cytology*; D014481:United States
D015704:CD4 Antigens; C057689:CD4-Pseudomonas toxin; D005098:Exotoxins; D006680:HLA Antigens; D000922:Immunotoxins; D016859:Lipoxygenase Inhibitors; D011994:Recombinant Proteins; C063449:zileuton; D006918:Hydroxyurea